Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Vaccine|February 17, 2024
2022 Polio outbreak, Rockland County, NY: Cost evaluation of strategies to prevent future outbreaks of vaccine-preventable diseasesJamison Pike, James Lueken, Julie Zajac, et al.Vaccine|January 26, 2021
Costs implications of pneumococcal vaccination of adults aged 30-60 with a recent diagnosis of diabetesDavid W Hutton, Jeffrey S McCullough, Lisa Prosser, et al.Drug and Alcohol Dependence|January 16, 2022
Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits - United States, April 2020-December 2020Amy R Board, Sunkyung Kim, Joohyun Park, et al.Health Affairs (Project Hope)|September 17, 2025
Comparing COVID-19 Acute And Postacute Medical Spending By Vaccination Status For Child And Adult Medicaid EnrolleesJamison Pike, Lyudmyla Kompaniyets, Laura P Hurley, et al.Journal of Public Health Management and Practice : JPHMP|February 27, 2019
Cost of Responding to the 2017 University of Washington Mumps Outbreak: A Prospective AnalysisJamison Pike, Sheryl Schwartz, Meagan Kay, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 15, 2022
Cost-Effectiveness Analysis of Vaccination With Recombinant Zoster Vaccine Among Hematopoietic Cell Transplant Recipients and Persons With Other Immunocompromising Conditions Aged 19 to 49 YearsAndrew J Leidner, Tara C Anderson, Kai Hong, et al.Pediatrics|March 13, 2021
Societal Costs of a Measles OutbreakJamison Pike, Alan Melnick, Paul A Gastañaduy, et al.MMWR. Morbidity and Mortality Weekly Report|February 11, 2021
Decline in COVID-19 Hospitalization Growth Rates Associated with Statewide Mask Mandates - 10 States, March-October 2020Heesoo Joo, Gabrielle F Miller, Gregory Sunshine, et al.Pediatrics|November 25, 2024
Cost-Effectiveness of Nirsevimab for Respiratory Syncytial Virus in Infants and Young ChildrenDavid W Hutton, Lisa A Prosser, Angela M Rose, et al.Pediatrics|November 25, 2024
Cost-Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus IllnessDavid W Hutton, Lisa A Prosser, Angela M Rose, et al.Pageof 4